Apogee Therapeutics CEO Sells 14,886 Shares at $78.64-$83.79/Share

Apogee Therapeutics, Inc. (APGE) reports that Director and Chief Executive Officer, Michael Thomas Henderson, has made various share sales on January 14, 2026. Specifically, he sold 1,440 shares at $78.64 each, 8,476 shares at $79.82 each, 2,374 shares at $81 each, 1,854 shares at $82.41 each, 5,386 shares at $83.16 each, and 470 shares at $83.79 each.